IDH2 and oligodendroglioma: In the primary group, composed of IDH-mutated tumors, the World Health Organization (WHO) 2021 classification recognizes oligodendroglioma (presenting 1p19q codeletion) and astrocytoma (without 1p19q codeletion) (4).